Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Universal Ibogaine Inc V.IBO

Alternate Symbol(s):  IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine... see more

Recent & Breaking News (TSXV:IBO)

UNIVERSAL IBOGAINE Engages Investor Relations Firm Blue Digital Media

TheNewsWire June 13, 2022

Universal Ibogaine Advises of Departure of David Danziger from the Board of Directors

TheNewsWire June 10, 2022

Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference

PR Newswire May 13, 2022

UNIVERSAL IBOGAINE RETAINS SHAYNE NYQUVEST AS CAPITAL MARKETS ADVISOR

PR Newswire April 29, 2022

Universal Ibogaine Advises of Departure of Marilyn Loewen Mauritz from the Board of Directors

TheNewsWire April 21, 2022

UNIVERSAL IBOGAINE PROVIDES UPDATE ON KELBURN RECOVERY CENTER OPERATIONS

PR Newswire April 7, 2022

Universal Ibogaine Announces Frankfurt Stock Exchange Listing

PR Newswire April 6, 2022

Universal Ibogaine to Participate in the 2022 Virtual Growth Conference - Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT

Canada NewsWire March 24, 2022

UNIVERSAL IBOGAINE EXPANDS RESEARCH TEAM WITH JULIE DUMOUCHEL, DIRECTOR OF CLINICAL TRIALS

Canada NewsWire March 23, 2022

Universal Ibogaine Announces Approval for Trading on the OTCQB Venture Market

Canada NewsWire February 28, 2022

Universal Ibogaine Signs Memorandum of Understanding with the Osoyoos Indian Band

PR Newswire February 10, 2022

UNIVERSAL IBOGAINE COMMENCES DEVELOPMENT PLAN AT KELBURN IN PREPARATION FOR IBOGAINE TREATMENTS AND PROVIDES UPDATE ON DRUG SUPPLY

PR Newswire February 2, 2022

The StockTalk Cannabis Report: Jan 28, 2022

Dave Jackson January 28, 2022

UNIVERSAL IBOGAINE ENTERS DRUG SUPPLY AGREEMENT

PR Newswire January 26, 2022

Kelburn Mental Health & Addiction Treatment Centre Announces New Ownership, New Leadership and New Modalities

PR Newswire January 19, 2022

UNIVERSAL IBOGAINE ANNOUNCES WORLD-CLASS CLINICAL TRIAL PARTNERS IN ADVANCE OF CLINICAL TRIAL APPLICATION OR IBOGAINE IN OPIOID USE DISORDER

PR Newswire January 14, 2022

The Power Play by The Market Herald Releases Interviews With Reyna Gold, Universal Ibogaine, NewRange Gold, Fabled Copper, and Fandom Sports Media

Accesswire January 11, 2022

Universal Ibogaine (TSXV:IBO) announces change in leadership

John Ballem  January 11, 2022

Universal Ibogaine Announces Change in Leadership

TheNewsWire January 10, 2022

Universal Ibogaine Announces Expansion of Executive Team andGrant of Stock Options

TheNewsWire December 2, 2021